COVID-19 Impact on Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 95 pages | ID: CBA7616A0419EN
QYResearch

Abstracts

This report focuses on the global Hypoactive Sexual Desire Disorder (HSDD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypoactive Sexual Desire Disorder (HSDD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AMAG Pharmaceuticals
• Allergan, Plc.
• Ivix LLX
• EndoCeutics, Inc.
• Emotional Brain BV
• S1 Biopharma, Inc.
• Sprout Pharmaceuticals, Inc.

Market segment by Type, the product can be split into

• Buspirone
• Bupropion
• Testosterone
• Flibanserin
• Bremelanotide
• Cognitive Behavior Therapy

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hypoactive Sexual Desire Disorder (HSDD) Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hypoactive Sexual Desire Disorder (HSDD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hypoactive Sexual Desire Disorder (HSDD) Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Buspirone
  1.4.3 Bupropion
  1.4.4 Testosterone
  1.4.5 Flibanserin
  1.4.6 Bremelanotide
  1.4.7 Cognitive Behavior Therapy
1.5 Market by Application
  1.5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry
    1.6.1.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Hypoactive Sexual Desire Disorder (HSDD) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Hypoactive Sexual Desire Disorder (HSDD) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2015-2026)
2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Regions
  2.2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hypoactive Sexual Desire Disorder (HSDD) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Market Size
  3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
  3.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2019
3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served
3.4 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
3.5 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2021-2026)

5 HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)
5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2015-2020)
6.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players in North America (2019-2020)
6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020)
6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2015-2020)
7.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020)
7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2015-2020)
8.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players in China (2019-2020)
8.3 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020)
8.4 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2015-2020)
9.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020)
9.4 Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2015-2020)
10.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2015-2020)
11.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players in India (2019-2020)
11.3 India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020)
11.4 India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2015-2020)
12.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AMAG Pharmaceuticals
  13.1.1 AMAG Pharmaceuticals Company Details
  13.1.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
  13.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
  13.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020))
  13.1.5 AMAG Pharmaceuticals Recent Development
13.2 Allergan, Plc.
  13.2.1 Allergan, Plc. Company Details
  13.2.2 Allergan, Plc. Business Overview and Its Total Revenue
  13.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
  13.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
  13.2.5 Allergan, Plc. Recent Development
13.3 Ivix LLX
  13.3.1 Ivix LLX Company Details
  13.3.2 Ivix LLX Business Overview and Its Total Revenue
  13.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
  13.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
  13.3.5 Ivix LLX Recent Development
13.4 EndoCeutics, Inc.
  13.4.1 EndoCeutics, Inc. Company Details
  13.4.2 EndoCeutics, Inc. Business Overview and Its Total Revenue
  13.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
  13.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
  13.4.5 EndoCeutics, Inc. Recent Development
13.5 Emotional Brain BV
  13.5.1 Emotional Brain BV Company Details
  13.5.2 Emotional Brain BV Business Overview and Its Total Revenue
  13.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
  13.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
  13.5.5 Emotional Brain BV Recent Development
13.6 S1 Biopharma, Inc.
  13.6.1 S1 Biopharma, Inc. Company Details
  13.6.2 S1 Biopharma, Inc. Business Overview and Its Total Revenue
  13.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
  13.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
  13.6.5 S1 Biopharma, Inc. Recent Development
13.7 Sprout Pharmaceuticals, Inc.
  13.7.1 Sprout Pharmaceuticals, Inc. Company Details
  13.7.2 Sprout Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
  13.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
  13.7.5 Sprout Pharmaceuticals, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
Table 3. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Buspirone
Table 6. Key Players of Bupropion
Table 7. Key Players of Testosterone
Table 8. Key Players of Flibanserin
Table 9. Key Players of Bremelanotide
Table 10. Key Players of Cognitive Behavior Therapy
Table 11. COVID-19 Impact Global Market: (Four Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Hypoactive Sexual Desire Disorder (HSDD) Treatment Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Hypoactive Sexual Desire Disorder (HSDD) Treatment Players to Combat Covid-19 Impact
Table 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2015-2020)
Table 20. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Strategy
Table 26. Main Points Interviewed from Key Hypoactive Sexual Desire Disorder (HSDD) Treatment Players
Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2015-2020) (Million US$)
Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players (2015-2020)
Table 29. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2019)
Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
Table 33. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Type (2015-2020)
Table 37. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2021-2026)
Table 38. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Application (2015-2020)
Table 39. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Application (2021-2026)
Table 41. North America Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share (2019-2020)
Table 43. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2015-2020)
Table 45. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2015-2020)
Table 47. Europe Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share (2019-2020)
Table 49. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2015-2020)
Table 51. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2015-2020)
Table 53. China Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (2019-2020) (Million US$)
Table 54. China Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share (2019-2020)
Table 55. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2015-2020)
Table 57. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2015-2020)
Table 59. Japan Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share (2019-2020)
Table 61. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2015-2020)
Table 63. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share (2019-2020)
Table 67. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2015-2020)
Table 69. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2015-2020)
Table 71. India Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (2019-2020) (Million US$)
Table 72. India Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share (2019-2020)
Table 73. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2015-2020)
Table 75. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share (2019-2020)
Table 79. Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2015-2020)
Table 81. Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2015-2020)
Table 83. AMAG Pharmaceuticals Company Details
Table 84. AMAG Pharmaceuticals Business Overview
Table 85. AMAG Pharmaceuticals Product
Table 86. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020) (Million US$)
Table 87. AMAG Pharmaceuticals Recent Development
Table 88. Allergan, Plc. Company Details
Table 89. Allergan, Plc. Business Overview
Table 90. Allergan, Plc. Product
Table 91. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020) (Million US$)
Table 92. Allergan, Plc. Recent Development
Table 93. Ivix LLX Company Details
Table 94. Ivix LLX Business Overview
Table 95. Ivix LLX Product
Table 96. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020) (Million US$)
Table 97. Ivix LLX Recent Development
Table 98. EndoCeutics, Inc. Company Details
Table 99. EndoCeutics, Inc. Business Overview
Table 100. EndoCeutics, Inc. Product
Table 101. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020) (Million US$)
Table 102. EndoCeutics, Inc. Recent Development
Table 103. Emotional Brain BV Company Details
Table 104. Emotional Brain BV Business Overview
Table 105. Emotional Brain BV Product
Table 106. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020) (Million US$)
Table 107. Emotional Brain BV Recent Development
Table 108. S1 Biopharma, Inc. Company Details
Table 109. S1 Biopharma, Inc. Business Overview
Table 110. S1 Biopharma, Inc. Product
Table 111. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020) (Million US$)
Table 112. S1 Biopharma, Inc. Recent Development
Table 113. Sprout Pharmaceuticals, Inc. Company Details
Table 114. Sprout Pharmaceuticals, Inc. Business Overview
Table 115. Sprout Pharmaceuticals, Inc. Product
Table 116. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020) (Million US$)
Table 117. Sprout Pharmaceuticals, Inc. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Buspirone Features
Figure 3. Bupropion Features
Figure 4. Testosterone Features
Figure 5. Flibanserin Features
Figure 6. Bremelanotide Features
Figure 7. Cognitive Behavior Therapy Features
Figure 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
Figure 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2019
Figure 18. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2019
Figure 20. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
Figure 29. Allergan, Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
Figure 31. Ivix LLX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
Figure 33. EndoCeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
Figure 35. Emotional Brain BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
Figure 37. S1 Biopharma, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
Figure 39. Sprout Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed